Lack of news leaves Lundbeck high and dry
Lundbeck has not had much news to report recently, and several analysts are struggling to pinpoint what is needed in the short term to give the Danish pharmaceutical company wind in its sails on the stock exchange.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
You might need a flashlight to make out what is keeping Lundbeck afloat at the moment.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck to push transport sector in greener direction
For subscribers
Lundbeck bets on four core products during hard year
For subscribers
.jpg&w=384&q=75)
